CN103239587B - 一种通络活血胶囊中药组合物的制备方法 - Google Patents
一种通络活血胶囊中药组合物的制备方法 Download PDFInfo
- Publication number
- CN103239587B CN103239587B CN201310206656.4A CN201310206656A CN103239587B CN 103239587 B CN103239587 B CN 103239587B CN 201310206656 A CN201310206656 A CN 201310206656A CN 103239587 B CN103239587 B CN 103239587B
- Authority
- CN
- China
- Prior art keywords
- group
- chinese medicine
- medicine composition
- capsule
- dredging collateral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 82
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 230000017531 blood circulation Effects 0.000 title abstract description 3
- 239000004863 Frankincense Substances 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 229940079593 drug Drugs 0.000 claims description 18
- 238000005325 percolation Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 10
- 241000717739 Boswellia sacra Species 0.000 claims description 5
- 241001489978 Eupolyphaga Species 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 241001057584 Myrrha Species 0.000 claims description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000010271 massa medicata fermentata Substances 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 230000007935 neutral effect Effects 0.000 claims description 5
- 239000009286 sanguis draxonis Substances 0.000 claims description 5
- 238000002474 experimental method Methods 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 19
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 208000008035 Back Pain Diseases 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 241001172538 Daemonorops draco Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 241001465251 Ephedra sinica Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 208000019804 backache Diseases 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 42
- 238000000034 method Methods 0.000 description 22
- 230000002496 gastric effect Effects 0.000 description 16
- 238000001802 infusion Methods 0.000 description 16
- 230000037396 body weight Effects 0.000 description 15
- 239000012153 distilled water Substances 0.000 description 14
- 241000700159 Rattus Species 0.000 description 12
- 230000008961 swelling Effects 0.000 description 10
- 238000012449 Kunming mouse Methods 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 208000026137 Soft tissue injury Diseases 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 230000036541 health Effects 0.000 description 6
- 206010057249 Phagocytosis Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000004089 microcirculation Effects 0.000 description 5
- 230000008782 phagocytosis Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 208000000114 Pain Threshold Diseases 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 230000037040 pain threshold Effects 0.000 description 4
- 210000003024 peritoneal macrophage Anatomy 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- -1 Dichlorodiphenyl Acetate Chemical compound 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 208000037976 chronic inflammation Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 230000033687 granuloma formation Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- ATADHKWKHYVBTJ-FVGYRXGTSA-N (R)-adrenaline hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=C(O)C(O)=C1 ATADHKWKHYVBTJ-FVGYRXGTSA-N 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000018650 Intervertebral disc disease Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 241001088162 Primula auricula Species 0.000 description 1
- 235000006894 Primula auricula Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310206656.4A CN103239587B (zh) | 2013-05-30 | 2013-05-30 | 一种通络活血胶囊中药组合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310206656.4A CN103239587B (zh) | 2013-05-30 | 2013-05-30 | 一种通络活血胶囊中药组合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103239587A CN103239587A (zh) | 2013-08-14 |
CN103239587B true CN103239587B (zh) | 2014-07-09 |
Family
ID=48919690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310206656.4A Expired - Fee Related CN103239587B (zh) | 2013-05-30 | 2013-05-30 | 一种通络活血胶囊中药组合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103239587B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1146352A (zh) * | 1996-09-17 | 1997-04-02 | 姚永全 | 骨筋康中药及其制造方法 |
-
2013
- 2013-05-30 CN CN201310206656.4A patent/CN103239587B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1146352A (zh) * | 1996-09-17 | 1997-04-02 | 姚永全 | 骨筋康中药及其制造方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103239587A (zh) | 2013-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102266501A (zh) | 一种结石通茶组合物及其制备方法 | |
CN101933991A (zh) | 一种镇痛抗炎药物及其制备方法 | |
CN103285060A (zh) | 一种用于活血止痛、去瘀生新的中药组合物及其制备方法 | |
CN102579669A (zh) | 一种用于补气血、调月经的中药组合物及其制备方法 | |
CN101912527A (zh) | 一种用于治疗风寒痹阻症的药剂及其制备方法 | |
CN103251765B (zh) | 一种治疗腰椎间盘突出症的中药组合物及其制备方法 | |
CN103239587B (zh) | 一种通络活血胶囊中药组合物的制备方法 | |
CN102526229B (zh) | 一种用于调经养血、理气化瘀的中药组合物及其制备方法 | |
CN102293847B (zh) | 一种用于治疗便秘、痤疮及高血脂的中药组合物及其制备方法 | |
CN102038821B (zh) | 一种治疗痛经的药物组合物制备方法 | |
CN103006832B (zh) | 一种升血小板中药组合物及其制备方法 | |
CN102940668A (zh) | 一种治疗心脑血管病的药物组合物 | |
CN106237181A (zh) | 一种治疗类风湿关节炎的中药组合物及其胶囊剂和制备方法 | |
CN101045116B (zh) | 一种治疗胆囊炎的中药药物 | |
CN102218103B (zh) | 亮叶杨桐叶提取物在制备抗炎镇痛药物中的应用 | |
CN103251582A (zh) | 5,7,3’,4’,5’-五甲氧基黄酮在制备镇痛抗炎药物中的应用 | |
CN102579899A (zh) | 一种骨刺消痛中药组合物及其制备方法 | |
CN103230568B (zh) | 一种小儿贝诺酯维b1颗粒及其制备工艺 | |
CN103238834A (zh) | 一种治疗皮肤瘙痒的组合物及其制备方法 | |
CN102670656B (zh) | 一种治疗中晚期肿瘤、慢性乙肝的中药肠溶胶囊及其制备方法 | |
CN102293816B (zh) | 一种治疗风湿病的滴丸的制备方法 | |
CN102441089B (zh) | 一种腰椎痹痛中药组合物及其制备方法 | |
CN101647841A (zh) | 地胆草及提取物的新应用 | |
CN100411679C (zh) | 元七骨痛制剂及其制备方法 | |
CN103751272B (zh) | 治疗强直性脊柱炎的中药组合物及其提取物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HARBIN KANGBAO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: YANG HAIJUAN Effective date: 20150427 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Sui Ming Inventor before: Yang Haijuan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YANG HAIJUAN TO: SUI MING Free format text: CORRECT: ADDRESS; FROM: 712100 XIANYANG, SHAANXI PROVINCE TO: 150040 HARBIN, HEILONGJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150427 Address after: 150040 No. 63, Wen Jie street, Power District, Heilongjiang, Harbin Patentee after: Harbin Canbo Pharmaceutical Co., Ltd. Address before: 712100 Shaanxi province Xianyang Changle Yangling District Road No. 8 Patentee before: Yang Haijuan |
|
ASS | Succession or assignment of patent right |
Owner name: YAO HONGFENG YAO HONGQING FU WENYUAN FANG YUSHAN S Effective date: 20150723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Sui Ming Inventor after: Yao Hongfeng Inventor after: Yao Hongqing Inventor after: Fu Wenyuan Inventor after: Fang Yushan Inventor before: Sui Ming |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUI MING TO: SUI MING YAO HONGFENG YAO HONGQING FU WENYUAN FANG YUSHAN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150723 Address after: 150040 No. 63, Wen Jie street, Power District, Heilongjiang, Harbin Patentee after: Harbin Canbo Pharmaceutical Co., Ltd. Patentee after: Yao Hongfeng Patentee after: Yao Hongqing Patentee after: Fu Wenyuan Patentee after: Fang Yushan Patentee after: Sui Ming Address before: 150040 No. 63, Wen Jie street, Power District, Heilongjiang, Harbin Patentee before: Harbin Canbo Pharmaceutical Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Harbin Canbo Pharmaceutical Co., Ltd. Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Harbin Canbo Pharmaceutical Co., Ltd. Document name: Notification of Termination of Patent Right |
|
DD01 | Delivery of document by public notice | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140709 Termination date: 20160530 |
|
CF01 | Termination of patent right due to non-payment of annual fee |